Catalyst Wire Dossier Catalyst Wire Dossier

Sanofi Pasteur recombinant protein COVID-19 vaccine formulations

SARS-CoV-2 recombinant protein vaccine · Sanofi Pasteur
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sanofi Pasteur recombinant protein COVID-19 vaccine formulations, covering 2023-06-22 to 2023-06-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older [Phase 1, Phase 2]

See pricing